首页>投融资
纽聆氪医疗
天使轮
纽聆氪医疗成立于2022年,总部坐落于长三角智创科技园(苏州市吴江区),在上海设有研发中心,专注于人体感知缺失康复的脑机接口解决方案的研发。目前公司核心研发产品为基于脑机接口技术的仿生眼和仿生耳,用于替代完全失明和失聪患者的感知器官,并会持续将脑机接口技术拓展到医疗康复的其他领域。核心创始团队多年来深耕于医疗器械行业,具有深厚学术背景和资源,从产品研发、生产、临床实验到注册认证在业有极强的优势。
基本信息
-
公司全称苏州纽聆氪医疗科技有限公司
-
类型脑机接口解决方案研发商
-
产业领域医疗器械、治疗设备
-
公司人数不明确
-
地址苏州市吴江区江陵街道芦荡路168号1号楼408室
-
联系电话
-
邮箱
-
成立时间2024-03-20
投融资
-
2024-06-01天使轮数千万人民币丹麓资本可孚医疗
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司,该公司开发了一种先进的放疗平台,能够对不可切除的实体瘤和手术切缘进行局部靶向治疗,称为YntraDose。